Sangamo Biosciences (SGMO) 17.55 $SGMO Sangamo

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sangamo Biosciences (SGMO) 17.55 $SGMO

Sangamo Biosciences (SGMO) is in Overbought Territory: What's Next? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 6:14AM CST
Sangamo Biosciences (SGMO) is in Overbought Territory: What’s Next?
SGMO: 17.55 (-0.51)

Strong On High Volume: Sangamo BioSciences (SGMO)
at The Street - Mon Mar 02, 9:02AM CST
Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a strong on high relative volume candidate
SGMO: 17.55 (-0.51)

Biogen's hemophilia B med successful in Phase 3 trial in children
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 8:59AM CST

BIIB: 417.63 (-7.98), ALNY: 107.67 (-3.89), OPK: 14.11 (-0.21), ONCE: 58.01 (+0.48), BAX: 67.73 (-1.48), SHPG: 235.75 (-2.31), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51)

The Top Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 22, 2:51AM CST

GFIG: 5.83 (+0.11), MATW: 46.36 (-1.03), RTIX: 5.32 (-0.03), ELLI: 51.40 (-0.66), KFRC: 22.15 (-0.23), SILC: 45.43 (+0.17), SGMO: 17.55 (-0.51), AFFX: 11.81 (-0.38), BABY: 35.54 (-0.45), HBIO: 5.58 (+0.07), EXAM: 39.64 (-0.06), IART: 59.15 (-0.96), UEIC: 55.16 (-0.70), CNMD: 50.44 (-0.98), BJRI: 51.63 (-0.88), NLNK: 48.65 (-0.28), CTRN: 25.74 (-0.47), ANAC: 47.18 (+0.36), CSU: 24.90 (-0.46), RRGB: 78.48 (-3.35), DIOD: 28.32 (+0.06), DEPO: 23.44 (-0.77), DYAX: 15.64 (-0.05), FARO: 53.91 (-2.22), PERY: 22.62 (-0.69), PACB: 6.17 (-0.22), PFPT: 55.39 (-1.50), MTSI: 33.21 (-0.61), IRWD: 15.81 (+0.04), ABAX: 62.39 (+0.24), SCSS: 31.82 (-0.39), ANIP: 66.72 (+0.21), FORM: 9.01 (-0.19), BEAT: 10.31 (-0.33), QLGC: 14.88 (-0.08), PENX: 18.84 (unch), EBIX: 25.17 (-0.20), CORT: 3.42 (-0.19), UTMD: 59.52 (-0.56), DAVE: 31.17 (-0.45), SWHC: 14.23 (-0.17)

Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), CVM: 1.06 (-0.08), MDGN: 8.35 (+0.17), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), RPRX: 9.84 (-0.01), MNKD: 5.47 (-0.26), CELG: 118.03 (-2.68), SGEN: 35.32 (-0.28), TEVA: 56.40 (-0.11), ARIA: 8.08 (-0.17), SNY: 47.42 (-0.94), REGN: 422.13 (-6.82)

Insider Trading Alert - ABMD, CCMP And SGMO Traded By Insiders
at The Street - Thu Feb 19, 10:15AM CST
Stocks with insider trader activity include ABMD, CCMP and SGMO
ABMD: 60.35 (-1.03), SGMO: 17.55 (-0.51), CCMP: 50.13 (-0.58)

Makers of pricey drugs working on new payment model
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 9:10AM CST

ABT: 46.50 (-0.94), BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), AMGN: 154.88 (-4.72), LLY: 68.41 (-2.18), BMY: 65.12 (-0.93), GSK: 46.73 (-0.87), CELG: 118.03 (-2.68), JNJ: 100.11 (-2.41), QURE: 24.62 (+1.77), GILD: 101.81 (-1.61), BAX: 67.73 (-1.48), MRK: 56.84 (-1.14), AZN: 66.27 (-1.91), NVS: 97.46 (-1.49)

A Look at the Latest Occurrences in the Healthcare Sector: Special Research on Sangamo BioSciences,Seattle Genetics, StemCells, Synageva and VBI Vaccines
PR Newswire - Thu Feb 19, 6:50AM CST
Editor Note: For more information about this release, please scroll to bottom.
GEVA: 103.20 (+1.96), SGEN: 35.32 (-0.28), STEM: 1.23 (-0.06), SGMO: 17.55 (-0.51), VBIV: 2.98 (+0.07)

Sangamo BioSciences - Gene Therapy To Invest In
Samreen Agha - at Seeking Alpha - Wed Feb 18, 11:55AM CST

SGMO: 17.55 (-0.51)

3 Stocks That Were Huge Winners Last Week
Todd Campbell, The Motley Fool - Motley Fool - Sat Feb 14, 11:29AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. The market's best-performing companies last week included...
JNJ: 100.11 (-2.41), BIIB: 417.63 (-7.98), PTLA: 41.72 (-0.13), SHPG: 235.75 (-2.31), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), BMY: 65.12 (-0.93), MOH: 61.27 (-1.00)

Sangamo BioSciences Presents Data At 11th Annual WorldSymposium(TM) Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders
PR Newswire - Thu Feb 12, 6:00AM CST
Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the presentation of preclinical data from its In Vivo Protein Replacement Platform (IVPRP) program for the development of proprietary ZFP Therapeutics® for the potential cure of lysosomal storage disorders (LSDs). The study was presented at the WORLDSymposium(TM) 2015 Meeting, a multidisciplinary forum presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases, which is being held in Orlando, Florida, from February 9-13, 2015. The data were generated by Sangamo scientists and their collaborators at the University of Minnesota and University of Massachusetts Medical School.
SGMO: 17.55 (-0.51)

4 Stocks Spiking on Big Volume: Akamai, Hydrogenics and More
at The Street - Wed Feb 11, 1:11PM CST
Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
HYGS: 14.82 (+0.04), AKAM: 69.96 (-1.13), SGMO: 17.55 (-0.51), FTI: 38.84 (-0.65)

Why Sangamo Biosciences Inc. Shares Rocketed Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Feb 11, 11:58AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Sangamo Biosciences shares surged more than 14%...
BIIB: 417.63 (-7.98), SHPG: 235.75 (-2.31), SGMO: 17.55 (-0.51)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 11:45AM CST

JIVE: 5.01 (-0.02), JONE: 8.68 (+0.26), FXEN: 1.83 (-0.03), CDTI: 1.98 (-0.02), SGMO: 17.55 (-0.51), EVRY: 1.00 (unch), INXN: 29.87 (-0.21), RLOC: 2.98 (-0.02), ATEN: 4.33 (-0.11), BLDP: 2.29 (-0.06), PNTR: 8.85 (+0.06), PRSS: 3.48 (-0.02), BXE: 2.99 (-0.06), ANTH: 6.12 (+0.59), PIR: 11.96 (-0.09), PSTR: 3.58 (-0.17), MKTO: 26.56 (-0.42), ANDE: 42.11 (-3.25), DGLY: 12.81 (+0.43), DCTH: 1.16 (+0.02)

Sangamo BioSciences ups revenues 117% in Q4
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:55AM CST

SGMO: 17.55 (-0.51)

Sangamo Biosciences' (SGMO) CEO Edward Lanphieron Q4 2014Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 10, 6:56PM CST

SGMO: 17.55 (-0.51)

Sangamo BioSciences (SGMO) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Feb 10, 3:55PM CST

SGMO: 17.55 (-0.51)

Sangamo BioSciences beats by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:05PM CST

SGMO: 17.55 (-0.51)

Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results
PR Newswire - Tue Feb 10, 3:02PM CST
Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its fourth quarter and full year 2014 financial results and accomplishments.
SGMO: 17.55 (-0.51)

Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 4:35PM CST

SGMO: 17.55 (-0.51), USNA: 98.80 (-0.77), RLOC: 2.98 (-0.02), ATEN: 4.33 (-0.11), VSAT: 64.50 (-0.25), RPXC: 14.23 (-0.06), TRMB: 26.10 (-0.25), KGC: 2.51 (-0.24), WSH: 47.21 (-0.56), TSRA: 39.92 (+0.26), FTI: 38.84 (-0.65), ACGL: 59.87 (-0.04), LOCK: 13.21 (-0.32), CERN: 69.97 (-2.54), CAP: 23.99 (-0.09), JIVE: 5.01 (-0.02), WU: 19.45 (-0.04), AKAM: 69.96 (-1.13), SKT: 34.13 (-0.92), NCR: 28.77 (-0.39), FRT: 137.11 (-4.74), SCI: 25.21 (-0.07), ELON: 1.16 (-0.01), GNW: 7.67 (+0.06), RKUS: 12.35 (-0.17), GHDX: 32.01 (-0.32), BLKB: 45.07 (-0.09), PXD: 156.17 (-4.27), SGEN: 35.32 (-0.28), OHI: 38.02 (-1.99), THOR: 39.50 (-0.83), MKTO: 26.56 (-0.42), CRL: 76.77 (-0.93), TMH: 57.11 (-1.15), ANDE: 42.11 (-3.25), XOOM: 16.09 (-0.37), HIW: 43.31 (-1.65), PAYC: 32.16 (-0.19)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ArcSpan AMS Nabs Top Honors at The Wires 2026

Updated Category News Views 78

ArcSpan Takes Center Stage with Prestigious Accolade ArcSpan just bagged the Best New Product or Service: Sell Side award at The Wires 2026. This ain't your average pat on the back. Taking place at the ritzy One Marylebone in London, this win springs from an event that celebrates the crème de la crème of digital advertising innovation. A Solid Win Amid The Changing Ad...

Continue Reading
LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 89

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading
NVCA Refreshes Key Venture Legal Documents for 2026

Updated Category News Views 41

Keeping Pace with Evolving Venture Norms Change never lets up in the fast-paced world of venture capital, does it? Just when you think you've got the rules figured out, the game shifts. This time, it's the National Venture Capital Association (NVCA) shaking things up. They've given a facelift to seven of their model legal documents, a move that reshapes the legal...

Continue Reading
Shareholder Alert: Investigation Looms Over GDYN

Updated Category News Views 26

Grid Dynamics Under Legal Scrutiny There’s nothing quite like waking up to find your pick embroiled in an investigation. Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) is on the radar, with law firm Levi & Korsinsky diving headfirst into potential infractions of fiduciary duties by some of the company’s top brass. The Lowdown on the Investigation This whole circus was...

Continue Reading
Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 119

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
Home Energy Tips: Embrace the Electrical Panel Shift

Updated Category News Views 45

Why Electrical Panels Matter More Than Ever Back in the day, electrical panels weren't exactly the star of the homeowner show. But times have changed, and those previously mundane boxes of switches and wires now demand a spotlight. Shifts in modern lifestyles have catapulted electrical systems into the spotlight, making upgrades a pressing conversation topic for savvy...

Continue Reading
ISC2 Launches AI Security Academy for Cyber Pros

Updated Category News Views 147

AI-Driven Threats Demand Expert Attention Every corner of the tech world has been blabbering about AI, but when it comes to cybersecurity, it's a whole different beast entirely. ISC2—a nonprofit that I like to think of as the cyber wizards’ guild—just threw a lifeline to cybersecurity folks who are swimming in the deep end of AI. With their shiny new AI Security...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 55

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 35

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 85

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover AM Best's New Bookstore for Insurance Insights

Updated Category News Views 92

AM Best Unveils Innovative Bookstore for Insurance Readers AM Best recently launched the AM Best’s Bookstore, a unique digital platform designed for those interested in deeper insights into the insurance sector. This bookstore serves as a central hub for information on newly published books that cover a wide range of topics pertinent to the insurance industry....

Continue Reading
Aurora Mobile Hits a Milestone with Strong Q2 Financials

Updated Category News Views 174

Aurora Mobile Reports Impressive Second Quarter Financial Results Aurora Mobile Limited, recognized for its customer engagement and marketing technology services, has revealed its financial metrics for the second quarter of 2025. This quarter has marked a groundbreaking achievement with the company recording its inaugural quarterly net income under U.S. GAAP. Financial...

Continue Reading
Meta Platforms' Competitive Edge in Media and Services Sector

Updated Category News Views 279

Understanding Meta Platforms in its Industry Context In the fast-paced realm of Interactive Media & Services, comprehensive analysis is vital for both investors and market analysts. This article dives into an industry comparison, focusing on Meta Platforms (NASDAQ: META) along with its prominent competitors. By evaluating crucial financial indicators, market standings,...

Continue Reading
Investigation by Rosen Law Firm for Kaspi.kz Investors

Updated Category News Views 88

Rosen Law Firm's Investigation of Kaspi.kz Security Claims The Rosen Law Firm, globally recognized for protecting investor rights, has launched an investigation regarding potential securities claims for shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI). This investigation stems from serious allegations that Kaspi.kz may have disseminated misleading business...

Continue Reading
Praxis Precision Medicines to Showcase Innovations This Fall

Updated Category News Views 158

Upcoming Investor Conferences for Praxis Precision Medicines Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a dynamic entity in the field of biopharmaceuticals, has an exciting roster of events lined up this fall. The company is dedicated to developing therapies aimed at addressing central nervous system (CNS) disorders that are driven by imbalances in neuronal...

Continue Reading